机译:Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
Division of Urology Department of Surgery American University of Beirut Medical Center;
Department of Medical Oncology Santa Chiara Hospital;
BC Cancer Vancouver Prostate Centre University of British ColumbiaResearch Department of Primary Care & Population Health Royal Free Campus University College LondonThe Christie and Salford Royal HospitalsMonash University and Eastern HealthThe Institute of Cancer Research Royal Marsden NHS Foundation TrustDepartment of Medical Oncology Hospital Universitario Marques de Valdecilla IDIVALHouston Methodist Cancer CenterDepartment of Radiation Oncology Massachusetts General HospitalDepartment of Surgery University of Port Harcourt Teaching HospitalUniversity of California Davis School of MedicineIRCCS Azienda Ospedaliero-Universitaria di BolognaUCSF Helen Diller Family Comprehensive Cancer Center University of California-San FranciscoInstitut Gustave Roussy University of Paris SaclayDepartment of Surgery Prostate Cancer Research Program Monash UniversityDepartments of Medicine and Surgery Duke Cancer Institute Duke UniversityUrological Sciences Vancouver Prostate Centre University of British ColumbiaDepartment of Biostatistics and Bioinformatics Duke UniversityDepartment of Oncology and Radiotherapy Innlandet Hospital TrustUniversity of British ColumbiaProstate Cancer Theranostics and Imaging Centre of Excellence Department of Molecular Imaging andRobert H. Lurie Comprehensive Cancer Center Northwestern UniversityInstitute of Cancer Sciences University of GlasgowDivision of Medical Oncology National Cancer CentreDepartment of Urology and the Naef K. Basile Cancer Institute American University of Beirut MedicalDivision of Urology Sunnybrook Health Sciences Centre University of TorontoOncology Institute Shamir Medical Center and Faculty of Medicine Tel-Aviv UniversityDepartment of Genitourinary Medical Oncology David H. Koch Centre MD Anderson Cancer CentreBeneficiência Portuguesa de S?o PauloPatient AdvocateDana-Farber Cancer Institute and Brigham and Women's Hospital Harvard Medical SchoolGenitourinary Oncology Service Department of Medicine Memorial Sloan Kettering Cancer CenterUniversity Jean MonnetNational Institute of Oncology Mohamed V UniversityDivision of Cancer Surgery Peter MacCallum Cancer CentreTata Memorial CentreDivision of Hematology and Medical Oncology Icahn School of Medicine at Mount Sinai The TischDepartment of Radiation Oncology Iridium NetwerkPatrick G. Johnston Centre for Cancer Research Queen's University Belfast Northern Ireland CancerComprehensive Oncology Centre Hong Kong Sanatorium & Hospital The Chinese University of Hong KongDepartment of Laboratory Medicine and Pathology University of WashingtonThe Cancer Research Chair College of Medicine King Saud UniversityUniversity of California-Los AngelesBern Center for Precision Medicine and Department for Biomedical ResearchMasonic Cancer Center University of MinnesotaCentre Hospitalier de Université de MontréalInstituto Alexander FlemingTulane Cancer CenterCarolina Urologic Research CenterRafal Masztak Grochowski Hospital and Maria Sklodowska Curie National Research Institute of OncologyMassachusetts General Hospital Cancer CenterProstate Cancer FoundationUniversity Hospitals Seidman Cancer CenterEnglander Institute for Precision Medicine Weill Cornell Medicine Division of Hematology andToho University Sakura Medical CenterMRC Clinical Trials Unit Institute of Clinical Trials and Methodology University College LondonMartini-Klinik Prostate Cancer Center University Hospital Hamburg-EppendorfCliniques Universitaires Saint LucDepartment of Urology M.A. Ayd?nlar Ac?badem University Altunizade HospitalDepartment of Urology Kindai University Faculty of MedicineRadboud University Medical CenterDepartment of Radiation Oncology & Cancer Epidemiology H. Lee Moffitt Cancer Center & ResearchDepartment of Urology Fudan University Shanghai Cancer CenterDepartment of Radiation Oncology Hospital Universitario de La Princesa Health Research InstituteDepartment of Medical Oncology and Haematology Cantonal Hospital St. GallenOncology Institute of Southern SwitzerlandDuke Cancer Institute Center for Prostate and Urologic CancersUniversity College London Cancer InstituteKnight Cancer Institute Oregon Health & Science UniversityDepartment of Urology Sk?ne University HospitalGenitourinary Oncology Prostate Brachytherapy UnitUnit of Urology/Division of Oncology Urological Research Institute IRCCS Ospedale San Raffaele VitaDivision of Cancer Sciences University of Manchester;
177Lu-PSMA therapy; Advanced prostate cancer; Castration-resistant prostate cancer; Genetics; Hormone-sensitive prostate cancer; Imaging; Next-generation sequencing; PARP inhibition; Prostate cancer treatment; Tumour genomic profiling;